Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies ; day:27 ; month:1 ; year:2022 ; pages:1-16
Neurotherapeutics ; (27.1.2022), 1-16
- Urheber
-
Dalakas, Marinos C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-022-01188-w
- URN
-
urn:nbn:de:101:1-2022050709015101046948
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dalakas, Marinos C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Complement activation contributes to GAD antibody-associated encephalitis
Spontaneous Downbeat Nystagmus in Anti-GAD-Antibody-Associated Paraneoplastic Syndrome
Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
Antibody engineering
Antibody therapeutics
Long latency between GAD-antibody detection and development of limbic encephalitis – a case report
Monoclonal antibody therapy
Antigen antibody interactions
Antibody Drug Conjugates
Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
Complement activation contributes to GAD antibody-associated encephalitis
Spontaneous Downbeat Nystagmus in Anti-GAD-Antibody-Associated Paraneoplastic Syndrome
Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
Antibody engineering
Antibody therapeutics
Long latency between GAD-antibody detection and development of limbic encephalitis – a case report
Monoclonal antibody therapy
Antigen antibody interactions
Antibody Drug Conjugates
Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates
Complement activation contributes to GAD antibody-associated encephalitis
Spontaneous Downbeat Nystagmus in Anti-GAD-Antibody-Associated Paraneoplastic Syndrome
Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor
Antibody engineering
Antibody therapeutics
Long latency between GAD-antibody detection and development of limbic encephalitis – a case report
Monoclonal antibody therapy
Antigen antibody interactions
Antibody Drug Conjugates